𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosets

✍ Scribed by R. K. B. Pearce; S. Costa; P. Jenner; C. D. Marsden

Publisher
Springer
Year
1999
Tongue
English
Weight
584 KB
Volume
106
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beginning-of-dose and rebound worsening
Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa
✍ Mikko Kuoppamäki; Ghassan Al-Barghouthy; Michael Jackson; Lance Smith; Bai-Yun Z 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

A wide range of motor fluctuations develop in Parkinson's disease (PD) patients after prolonged levodopa (L-dopa) treatment, but few experimental models exist in which these can be investigated. We report on motor fluctuations occurring in MPTP-treated common marmosets (Callithrix jacchus) treated r

Entacapone enhances levodopa-induced rev
Entacapone enhances levodopa-induced reversal of motor disability in MPTP-treated common marmosets
✍ Lance A. Smith; Ariel Gordin; Dr. Peter Jenner; C. David Marsden 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 883 KB

Oral administration of levodopa (L-dopa) (2.5-25.0 mg/kg) plus carbidopa (12.5 mg/kg p.o.) to MPTP-treated common marmosets produced a dose-related increase in locomotor activity and a corresponding decrease in motor disability. Pretreatment with the peripheral COMT inhibitor entacapone (12.5 mg/kg

Antiparkinsonian activity of L-propyl-L-
Antiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets
✍ Regina Katzenschlager; Michael J. Jackson; Sarah Rose; Kim Stockwell; Kayhan A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

## Abstract The neuropeptide melanocyte‐inhibiting factor (MIF) or L‐propyl‐L‐leucyl‐glycinamide (PLG) has been reported in some studies to improve the motor signs of Parkinson's disease (PD) and in rodent models of PD. In this study of oral and intravenous MIF in __N__‐methyl‐4‐phenyl‐1,2,3,6‐tetr

Repeated administration of piribedil ind
Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: A behavioural and biochemical investigation
✍ Lance A. Smith; Banu C. Tel; Michael J. Jackson; Matthew J. Hansard; Rogelio Bra 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB

## Abstract Piribedil ([1‐(3,4‐methylenedioxybenzyl)‐4‐(2‐pyrimidinyl)piperazine]; S 4200) is a dopamine agonist with equal affinity for D~2~/D~3~ dopamine receptors effective in treating Parkinson's disease as monotherapy or as an adjunct to levodopa (L‐dopa). However, its ability to prime basal g